TORONTO, March 4, 2022 /CNW/ – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) (“Pathway” or the “Company”), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announces that it has entered into a Letter of Intent (the “LOI”) to acquire the operating assets of National Cannabinoid Clinics Inc. (“NCC”). The acquisition of NCC’s operating assets adds approximately 1,500 active patients to the Company’s existing base and continues to expand the Company’s telemedicine footprint in Canada. Management expects to close the transaction in the second quarter of the fiscal 2022.
“The potential tuck-in acquisition of NCC’s operating assets will continue to expand the number of patients across Canada that have access to our products and services,” said Ken Yoon, CEO of Pathway Health. “We believe using cannabinoids for medical purposes is in its infancy in Canada,” continued Yoon, “and with our strong partnership position with some of the largest Canadian retail pharmacy corporations, we are well positioned for the cannabinoid-based health products (“CHPs”) opportunity.”
